Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Surg. Sep 27, 2022; 14(9): 918-929
Published online Sep 27, 2022. doi: 10.4240/wjgs.v14.i9.918
Table 1 Clinical characteristics and therapeutic outcomes of 90 patients with submucosal tumors originating from the muscularis propria layer in the esophagogastric junction
Variable
Number
Age, median (range), yr55.5 (25.0–74.0)
Male/Female, n (%)42/48 (46.7/53.3)
Location, n (%)
Esophagocardia25 (27.8)
Cardia26 (28.9)
Gastrocardia39 (43.3)
Tumor diameter, median (range), mm20.0 (5.0–100.0)
Shapes of lesion, n (%)
Regular47 (52.2)
Irregular43 (47.8)
Growth pattern, n (%)
Predominant extraluminal17 (18.9)
Predominant intracavitary73 (81.1)
Surface, n (%)
Smooth77 (85.6)
Reddish and erosive13 (14.4)
Surgical approach, n (%)
STER44 (48.9)
EFTR14 (15.6)
ESD32 (35.5)
En bloc resection, n (%)76 (84.4)
Operation time, median (range), min43 (16–126)
Intraoperative bleeding, n (%)
Bleeding group17 (18.9)
No bleeding group73 (81.1)
Histopathology, n (%)
Leiomyoma71 (78.9)
GIST18 (20.0)
Schwannoma1 (1.1)
Follow-up time, median (range), months16.4 (6.0–26.0)